Results 321 to 330 of about 5,734,618 (390)
Oxygen‐doping modulated g‐C3N4 support enables a strong built‐in electric field (BIEF) in FeOCl‐OCN.This enhanced BIEF induces the rearrangement of Fe(II)/Fe(III) in FeOCl, which subtly improves intermediates adsorption and also reduces the energy barrier of *O production, thereby achieving efficient PMS activation with 1O2 and Fe(IV)= O as the primary
Ying Zeng+9 more
wiley +1 more source
A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database. [PDF]
Shi X, Wang C, Liu X, Zou L, Guo P.
europepmc +1 more source
A simulation technique for assessing both the fabrication and operation of a solid‐state Si battery is demonstrated by integrating particle dynamics with mass/charge transport. Although, the fabrication pressure (Pfab) increased the inter‐particle contacts and reduced the concentration (ηconc) and Li‐ion (ηLi+) overpotentials during discharging, it ...
Magnus So+4 more
wiley +1 more source
A real-world safety surveillance study of aducanumab through the FDA adverse event reporting system. [PDF]
Huang J, Long X, Chen C.
europepmc +1 more source
This study introduces a paper‐based biodegradable, humidity‐insensitive e‐nose for real‐time breath analysis, addressing challenges in existing technologies such as humidity interference, high costs, and environmental impact. Featuring hydrophobic polymer coatings, these sensors reliably detect VOCs even in high‐moisture environments.
Indrajit Mondal+2 more
wiley +1 more source
Acquired Generalized Lipodystrophy as an Adverse Event of Combined Immune Checkpoint Inhibitor Therapy. [PDF]
Kennedy R+5 more
europepmc +1 more source
Designer DNA Architecture‐templated Drug Conjugates (DDA‐DCs) are comprised of a DNA nanomaterial decorated with multiple drug‐loaded DNA aptamers. DDA‐DCs use a combination of multiple aptamer types, each recognizing a different membrane protein to achieve precise targeting of cancer cells.
Abhisek Dwivedy+19 more
wiley +1 more source
Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]. [PDF]
Yang F, Ge W.
europepmc +1 more source